Full Time Faculty: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Joint Faculty
Emeritus Faculty
Voluntary Faculty
Faculty Publications
Information for Faculty

Faculty Publications

• Recent Faculty Publications
• Academic Year 2004-2005
• Academic Year 2002-2003
• Academic Year 2001-2002
• Academic Year 2000-2001
• Academic Year 1999-2000
• Academic Year 1998-1999

Faculty Publications for Academic Year 1998-1999
From the Annual Report of 1999

*Listed in alphabetical order by most senior author (highlighted) from the Department of Laboratory Medicine

• Anderson GM, Leckman JF, Cohen DJ: Neurochemical and Neuropeptide Systems, in Tourette's Syndrome, JF Leckman and DJ Cohen eds., New York, J.Wiley and Sons, Inc. pp 261-281, 1998.
   
• Cubells JF, van Kammen DP, Kelley ME, Anderson GM, O'Connor DT, Price LH, Malison R, Rao PA, Kobayashi K, Nagatsu T, and Gelernter J: Dopamine $-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation in plasma and cerebrospinal fluid. Hum Genet, 102:533-540, 1998.
   
• Cubells JF,. Kranzler HR, McCance-Katz E, Satel S, Anderson GM, Malison R, Price L, Gelernter J: A haplotype at DBH, associated with low plasma dopamine-$-hydroxylase activity, also associates with cocaine- induced paranoia. Molecular Psychiatry, (in press, 1999).

 

• Martin A, State M, Anderson GM, Kaye WM, Hanchett JM, McConaha CW, North WG, Leckman JF:Cerebrospinal fluid levels of oxytocin in Prader-Willi syndrome: a preliminary report. Biological Psychiatry, 44:1349-1352, 1998.
   
  
• McBride PA, Anderson GM, Hertzig ME, et al.: Effects of diagnosis, race, and pubertal status on platelet serotonin levels in autism and mental retardation. Journal of the American Academy of Child & Adolescent Psychiatry, 37:767-779, 1998.
   
  
• Peterson BS. Zhang H. Anderson GM. Leckman JF: A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome. Journal of Clinical Psychopharmacology, 18:324-31, 1998.
   
  
• Pfeffer CR, McBride PA, Anderson GM, Kakuma T, Fensterheim L, Khait V: Peripheral serotonin measures in prepubertal psychiatric inpatients and normal children: associations with suicidal behavior and its risk factors. Biological Psychiatry, 44:568-77, 1998.
   
  
• van Wattum PJ, Anderson GM, Chappell PB et al.: Cerebrospinal fluid dynorphin A[1-8] and B-endorphin levels in Tourette's syndrome are unaltered. Biological Psychiatry, 45:1527-1528, 1999.
   
  
• Hasbun R and Bia FJ: Intestinal Parasites.Conn's Current Therapy 1999 Edition. R.E. Rakel, ed., W.B. Saunders Co., Philadelphia PA, 1999.
   
  
• Bleck TP, Danesi M., Bia FJ: Approach to the patient with neurologic disease. Tropical Infectious Diseases, Principles, Pathogens and Practice. Guerrant RL, Krogstad, DJ, Maguire JH, Walker DH, Weller PF, eds., Churchill Livingstone, 1998.
   
  
• Mileno MD, Bia FJ. The Compromised Traveler. Infect Dis Clin North America 12: 369-412, 1998
   
  
• Buitrago MI, Ijdo JW, Rinaudo P, Simon H, Copel J, Gadbaw J, Heimer R, Fikrig E, Bia FJ: Human granulocytic ehrlichiosis (HGE) during pregnancy successfully treated with rifampin. Clin Infect Dis 27: 2-13-215, 1998
   
  
• Gupta AR, Wells CK, Horwitz RI, Bia FJ, Barry M. International Health Program: the fifteen year experience with Yale University's Internal Medicine Residency Program. Am J Trop Med Hyg, 1999 (in press) Journal of ASTMH
   
  
• Booss J. Prefactory Comments, Supplement to Alzheimer Disease and Associated Disorders. (in press)
   
  
• Post MJD, Yiannoutsos C, Simpson D, Booss J, Clifford D, Hall C, et.al. PML in AIDS: An MR/Neurological/Pathologic Correlation. Are There Any MR or Neurologic Findings Predictive of Patient Survival- Amer J Neurprad (in press)
   
  
• Guarnaccia JB, Kazis L, Kashner TM, Collins D, O'Connor T, Hope MA, Brennan J, Hunter B, Booss J. Costs, Quality of Life and Functional Outcomes of Veterans with Multiple Sclerosis (MS) Treated with Interferon Beta. Abstract for the Multiple Sclerosis Consortium Meeting, Cleveland, Ohio, October 14, 1998.
   
  
• Auld E, Guarnaccia J, Booss J, et.al. The Veterans Health Administration as Provider of Comprehensive MS Care. Abstract for the multiple Sclerosis consortium Meeting, Cleveland, Ohio, October 1-4, 1998.
   
  
• Gruen, R.J., Stoker, S, Friedhoff, A.J., and Bradberry, C.W. Effects of repeated amphetamine treatment on regional GABAA binding. Brain Res., 825: 180-182, 1999
   
  
• Youngren KD, Inglis FM, Pivirotto PJ, Jedema HP, Bradberry CW, Goldman-Rakic PS, Roth RH, and Moghaddam B, Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus, Neuropsychopharmacology, 20: 403-412, 1999
   
  
• Bradberry, C.W., Lee, T., and Jatlow, P. Rapid induction of behavioral and neurochemical tolerance to cocaethylene, a model compound for agonist therapy of cocaine dependence.Psychopharmacology, 146: 87-92, 1999.
   
  
• Campbell SM and Olsen D. Diarrhea in a Pancreatic Transplant, Cyberounds in Laboratory Medicine 1999.
   
  
• Cotmore S.F. and Tattersall P. High Mobility Group (HMG1/2) Proteins are Essential for Initiating Rolling-Circle Type DNA Replication at a Parvoviral Hairpin Origin. J. Virol. 72, Nov 1998.
   
  
• Cotmore S.F., D'Abramo A.M. Jr., Ticknor C.M. and Tattersall P. Controlled Conformational Transitions in the MVM Virion Expose the VP1 N-Terminus and Viral Genome without Particle Disassembly. Virology, 254, 169-181,1999.
   
  
• Kestler J., Neeb B., Struyf S., Van Damme J., Cotmore S.F., D'Abramo A., Tattersall P., Rommelaere J., Dinsart C. and Cornelis J.J. Cis-Requirements for the Efficient Production of Recombinant DNA Vectors Based on Autonomous parvoviruses. Human Gene Therapy, 10, 1619-1632, 1999.
   
  
• Christensen J., Cotmore S.F. and Tattersall P. Two New Members of the Emerging KDWK Family of Combinatorial Transcription modulators Bind as a Heterodimer to Flexibly-Spaced PuCGPy Half-Sites. Mol. Cell. Biol., 19, 7741-7750, 1999.
   
  
• Edberg, S.C. Microbiology of Treated Bottled Water, In: Technology of Bottled Water. D.A.G. senior and P.R. Ashurst (eds). Sheffield Academic Press, Sheffield, England, pp. 274-288, 1998.
   
  
• Abdala N, Stephens PC, Griffith PB, Heimer R. Survival of human imunodeficiency virus type 1 in injection syringes. J. Acq Immuno Def Synd Human Retro 20:73-80, 1999.
   
  
• Lin PF, Gonzoles CJ, Griffith BP, Friedland G, Calvez V, Ferchal F, Schinazi RF, Shepp DH, Ahsraf AB, Wainberg M, Soriano V, Mellors JW, Colonno RJ, Stavudine resistance an update on susceptibility following prolonged therapy. Antiviral Therapy 4:21-28, 1999.
   
  
• Friedland GH, Pollard R, Griffith BP, Hughes M, Morse G, Bassett R, Freimuth W, Demeter L, Connick E, Nevin T, Hirsch M, Fischi M, for the ACTG 261 Team. The efficacy and safety of Delavirdine Mesylate in Combination with Zidovudine and Didanosine in the treatment of HIV Disease in persons with CD4 cell counts from 100-500 cells/mm3 (ACTG 261). J. Acq Immuno Def Synd Human Retro (in press)
   
  
• McCance-Katz EF, Kosten TR, Jatlow P. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either drug along--a multiple dose study Biological Psychiatry 44:250-259, 1998.
   
  
• Kosten TA, Haile CN, Jatlow PI, Naltrexone and morphine alter the discrimination and plasma levels of ethanol. Behavioral Pharmacology 10:1-13, 1998.
   
  
• Fujita M, Woods SW, Paul N, Verhoeff LG, Abi-Dargham A, Baldwin RM, Zoghbi SS, Soares, JC, Jatlow PI, Krystal JH, Rajeevan N, Charney DS, Seibyl JP, INNIS RB., "Changes of benzodiazephine receptors during chronic benzodiazepine administration in Humans" Eur J Pharmacol 368:161-172, 1999.
   
• Brodkin ES, Kosten TA, Haile CN, Heninger GR, Carlezon WA, Jatlow P, Remmers EF, Wilder RL, Nestler EJ, "Dark Agouti and Fischer 344 rats: Differential behavioral responses to morphine and biochemical differences in the ventral tegmental area." Neuroscience 88:1307-1315, 1999.
   
  
• Bradberry CW, Lee T, Jatlow P. Rapid induction of behavioral and neurochemical tolerance to cocaethylene, a model compound for agonist therapy of cocaine dependence. Psychopharmacology, 146: 87-92, 1999.
   
  
• Kieffer, L. and Kavathas, P.B. A Modified Cell Surface Marker Gene for Transgenic Animal Studies. NAR. 26:5228-5229, 1998.
   
  
• Devine, L., Sun, J., Barr, M.R., and Kavathas, P.B. Orientation of the Ig-like domains of CD8"$ relative to MHC Class I. J. Immunol. 162:846-851, 1999.
   
  
• Devine, L., and Kavathas, P.B. Molecular analysis of protein interactions mediating the function of the cell surface protein CD8. Immunol. Res. 19(2-3):201-210, 1999.
   
  
• Devine, L., Kieffer, L.J., Aitken, V., and Kavathas, P.B. Human CD8$, but not mouse CD8$ can be expressed in the absence of CD8" as a $$ homodimer. Submitted.
   
  
• Chabannon, C., Cornetta, K., Lotz, J-P., Rosenfeld, C. Shlomchik, M., Yanovitch, S., Marolleau, C., Sledge, G., Novakovitch, G., Strour, E.F., Burtness, B., Camerlo, J., Gravis, G., Lee-Fischer, J., Faucher, C., Chabbert, I., Krause, DS., Maraninchi, D., Mills, B., Kunkel, L., Oldham, F., Blaise, D., Viens, P. High dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with advanced breast cancer: a randomized multicentre study. British Journal of Cancer, ( in press)
   
  
• Burtness BA, Psyrri A, Rose M, D'Andrea E, Staugaard-Hahn C, Henderson-Bakas M, Clark MB, Mechanic S, Krause DS, Snyder E, Cooper RB, Abrantes J, Corringham R, Deisseroth A, Cooper DL. A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells. Bone Marrow Transplantation 23, 311-15, 1999.
   
  
• Radomska HS, Satterwaithe AB, Taranenko N, Narravula S, Krause DS, Tenen DG. A nuclear factor Y site positively regulates the human CD34 stem cell gene. Blood, (in press)
   
  
• Donnelly DS, Zelterman D, Sharkis.S, Krause DS. Functional Activity of Murine CD34+ and CD34- Hematopoietic Stem Cell Populations. Experimental Hematology 27, 788-796, 1999.
   
  
• Yanovich S, Mitsky P, Cornetta K, Maziarz RT, Rosenfeld C, Krause DS, Lotz JP, Bitran JD, Williams S, Preti R, Somlo G, Mills B. Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: Results of a prospective randomized multicenter clinical trial. Bone Marrow Transplantation, (in press)
   
  
• Seropian S, Ferguson D, Salloum E, Cooper D, Landry ML. Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV disease following allogeneic bone marrow transplant. Bone Marrow Transplantation 22:507-509, 1998.
   
  
• Smith PT, Landry ML, Carey H, Krasnoff J and Cooney E. Papular-purpuric gloves and socks syndrome associated with acute parvovirus B19 infection: A case report and review of the literature. Clin Infect Dis 27:164-168, 1998.
   
• Landry, M.L. Rhinoviruses. In: Manual of Clinical Microbiology, 7th Edition, American Society of Microbiology, Washington DC, 1999.
   
  
• Landry, M.L. and Hsiung, G.D. Diagnostic Techniques. Isolation and Identification by Culture and Microscopy. In: Encyclopedia of Virology, Academic Press Ltd, London, 1999.
   
  
• Landry ML. Viral infections in pregnancy. In Duffy TP and Burrows GN, Eds, Medical complications during pregnancy, 5th Edition, WB Saunders Co, Philadelphia PA 1999.
   
• Landry, ML and Hsiung, GD. Primary isolation of viruses. In: Clinical Virology Manual, Specter SS, Hodinka R and Young S (Eds), 3rd edition, American Society for Microbiology Press, Washington, D.C. (in press)
   
  
• Landry ML, Cohen S, Ferguson D. Impact of sample type on detection of influenza A virus by cytospin-enhanced immunofluorescence and membrane ELISA. J Clin Microbiol (in press)
   
  
• Landry ML, Ferguson D. Two hour cytomegalovirus pp65 antigenemia assay for rapid quantitation of cytomegalovirus in blood samples. J Clin Microbiol (in press)
   
  
• Landry ML, Stanat S, Biron K, Brambilla D, Britt W, Jokela J, Chou S, Drew L, Erice A, Gilliam B, Lurain N, Manischewitz J, Miner R, Pollard R, Reichelderfer P, Spector S, Weinberg A, Yen-Lieberman B, Crumpacker C.Standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. Antimicrob Agents Chemother (in press)
   
  
• Landry ML, Ferguson D. Rapid screen for detection of multiple respiratory viruses in clinical specimens by cytospin-enhanced immunofluorescence. J Clin Microbiol (in press)
   
  
• Leitenberg, D., Boutin Y., Constant S., and Bottomly K. CD4 regulation of T cell receptor signaling and T cell differentiation following stimulation with peptides of different affinities for the T cell receptor. J. Immunol. 161:1194-1203. 1998
   
  
• Welte, T., Leitenberg, D., Dittel, B.N., Al-Ramadi, B.K., Xie, B., Chin, Y.E., Janeway, C.A., Bothwell, A.L.M., Bottomly, K., and Fu, X-Y. 1999. STATS interaction with the T cell receptor complex and stimulations of T cell proliferation. Science. 283:222-225.
   
  
• Geiger, T., L., Leitenberg, D., Flavell, R. A., 1999. The T cell receptor zeta chain immunoreceptor tyrosine-based activation motifs are sufficient for the activation and differentiation of primary T lymphocytes. J. Immunol. 162:5931-5939.
   
  
• Leitenberg, D., Boutin, Y., Lu, D., and Bottomly, K. Specific biochemical association of CD45 with the T cell receptor: regulation by CD45 isoform and during T cell activation. Immunity. 10:701-711.
   
  
• Leitenberg, D., and Bottomly, K. Regulation of naive T cell differentiation by varying the potency of TCR signal transduction. Seminars in Immunology. 11:283-292.
   
  
• Mayer, S., Pascale, JLR., Clyne, LP., Malkus, H., Santos, FS., von Hoff, J. Stability of low-dose vancomycin hydrochloride in heparin sodium 100 IU/ml. J. Pharm. Technol., 1999:15:13-17.
   
  
• McPhedran P. Hematologic complications of human immunodeficiency virus (HIV) and their treatment. Current Practice of Medicine 2:1195-1205, June, 1999.
   
  
• Sundar S, Sinha PR, Agrawal NK, Srivastava, Rainey PM, Berman JD, Murray HW and Singh VP. A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high osmolarity lot of sodium antimony gluconate, Am J Trop Med Hyg 1998;59:139-43.
   
  
• Rainey PM. Outcomes Assessment for Point-of-Care Testing [Editorial]. Clin Chem 1998;44:1595-6.
   
  
• McCance-Katz EF, Rainey PM, Jatlow P. and Friedland G. Methadone Effects on Zidovudine Disposition (ACTG 262) J Acquir Immune Defic Syndr 1998;18:435-443.
   
  
• Schumacher C, Brodkin CA, Alexander B, Cullen M, Rainey PM, van Netten C, Faustman E and Checkoway H. Thyroid function in lead smelter workers: Absence of subacute or cumulative effects with moderate lead burdens. Int Arch Occup Environ Health 1998;71:453-458.
   
  
• Armstrong LR, L.-Dembry L-M, Rainey PM, Russi MB, Khan AS, Fischer SH, Edberg SC, Ksiazek TG, Rollin PE and Peters CJ. Management of a Sabia-infected patient in a US Hospital. Infect Control Hosp Epidemiol 1999;20(3):1-8.
   
  
• Rainey P. Digibind and Free Digoxin [letter]. Clin Chem 1999;45:719-720.
   
  
• Roberts WL, Smith PT, Martin WJ and Rainey PM. Performance Characteristics of Three Serum Iron and Total Iron-binding Capacity Methods in Acute Iron Overdose. Am J Clin Pathol (in press).
   
  
• Grossman D, Heald PW, Wang C, Rinder HM. Activated protein C resistance and anticardiolipin antibodies in patients with venous stasis leg ulcers. J Am Acad Dermatol 37:409-13, 1997
   
  
• Rinder HM, Schuster JE, Rinder CS, Wang C, Schweidler HJ, Smith BR. Correlation of thrombosis with increased platelet turnover in primary and secondary thrombocytosis. Blood 91:1288-94, 1998
   
  
• Varelas PN, Sleight BJ, Rinder HM, Sze G, Ment LR. Stroke in a neonate heterozygous for factor V Leiden. Ped Neuro 18:262-264, 1998.
   
  
• Rinder HM, Snyder EL. Heparin-induced thrombocytopenia in Diagnostic Challenges: Emerging Recombinant Cardiovascular Therapeutics, Bell, Brinker, and Gerstenblith (eds). Medical Age Publishing, Norwalk, CT, 1998.
   
  
• Rinder HM, Rinder CS: Analysis of leukocyte-platelet adhesion; in Flow Cytometry of the Megakaryocyte and Platelet System, eds. Scharf R and Clemetson K. Elsevier (in press).
   
  
• Rinder HM, Tracey JB, Recht M, DeCastro L, Rinder CS, McHugh C, Smith BR. Differences in platelet "-granule release between normal and immune thrombocytopenic patients and between young and old platelets. Thrombos Haemostas (in press).
   
  
• Rinder HM, Ault KA. Detection of platelet activation during preparation of platelets for transfusion. Transfus Med Rev (in press).
   
  
• Rinder, HM. Platelet Function Testing by Flow Cytometry. Clin Lab Science (in press).
   
  
• Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189:1639-1648, 1999
   
  
• Chan OTM, Madaio MP, Shlomchik MJ. The central and multiple roles of B cells in lupus pathogenesis. Immunol. Rev. 169:107-121, 1999
   
  
• Dal Porto JM, Haberman AM, Shlomchik MJ, Kelsoe G: Antigen drives very low affinity B cells to become plasmacytes and enter germinal centers. J Immunol 161:5373-81, 1998
   
  
• Chabannon C, Cornetta K, Lotz JP, Rosenfeld C, Shlomchik M, Yanovitch S, Marolleau JP, Sledge G, Novakovitch G, Srour EF, Burtness B, Camerlo J, Gravis G, Lee-Fischer J, Faucher C, Chabbert I, Krause D, Maraninchi D, Mills B, Kunkel L, Oldham F, Blaise D, Viens P: High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study. Br J Cancer 78:913-21, 1998.
   
  
• Rinder HM, Schuster, JE, Rinder CS, Wang C, Schweidler HJ, Smith BR. 1998. Correlation of Thrombosis with Increased Platelet Turnover in Thrombocytosis. Blood 91:1288-1294.
   
  
• Smith BR. 1999. Blood. In: "Microsoft Encarta Encyclopedia" (Microsoft Press, Redmond, WA).
   
  
• Smith BR. 1999. Stem Cell Biology. In: Snyder ES, Haley R. "Basic Biology of Stem Cell Transplantation" (AABB Press, Bethesda, MD) (in press).
   
  
• Smith BR. 1998. Commentary on: "Intercellular adhesion molecule-1 regulation in the canine lung after cardiopulmonary bypass" Dreyer WJ, Burns AR, Phillips SC, Lindsey ML, Jackson P, Kukielka GL. Journal of Thoracic and Cardiovascular Surgery 115(3): 698-699.
   
  
• Smith BR. 1998. Interaction of Blood and Artificial Surfaces. In: Schafer AI, Loscalzo J. "Thrombosis and Hemorrhage, 2nd Edition" (Williams and Wilkins, Baltimore, MD) pp. 925-941.
   
  
• Crotty PL, Smith BR, Tallini G. 1998. Morphologic, immunophenotypic and molecular evolution of bone marrow involvement in non-Hodgkin's lymphoma. Diag Mol Path 7 (2): 90-95.
   
  
• Rinder HM. Tracey JB. Recht M. DeCastro L. Rinder CS. McHugh C. Smith BR. 1998. Differences in platelet alpha-granule release between normals and immune thrombocytopenic patients and between young and old platelets. Thrombosis & Haemostasis. 80 (3): 457-62.
   
  
• Rinder CS, Rinder HM, Johnson K, Smith M, Lee D, Tracey J, Polock G, Higgins P, Yeh CG, Smith BR. 1999. Role of C3 Cleavage in Monocyte Activation during Extracorporeal Circulation. Circulation 100: 553-558.
   
  
• Harris SN, Rinder CS, Rinder HM, Tracey JB, Smith BR, Hines RL. 1999. Platelet function in sequestered fresh whole blood--a comparison of three storage techniques for intraoperative transfusion. J Cardiothoracic and Vascular Anesthesia (in press).
   
  
• Jillella AP, Doria R, Khan K, Zelterman D, Ahmad YH, Smith BR, Holmes W, Becker P, Roberts KB, Rappeport JM. 1999. Cyclophosphamide, Cytosine Arabinoside and TBI as conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia. Bone Marrow Transplantation 23:1095-1100.
   
  
• Smith BR. 1999. Book Review: Tumor Marker Protocols, edited by Margaret Hanausek and Zbigniew Walaszek (Humana Press, 1999) Quarterly Rev of Biology 74(1):116-117, 1999.
   
  
• Rinder CS, Rinder HM, Smith MJ, Tracey JB, Fitch JCK, Li L, Rollins SA, Smith BR. 1999. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation. J Cardiovasc Thor Surgery 118:460-464, 1999.
   
  
• Fitch JCK, Rollins S, Matis L, Alford B, Aranki S, Collard D, Dewar M, Elefleriades J, Hines R, Kopf G, Kraker P, Li L, O'Hara R, Rinder C, Rinder H, Shaw R, Smith BR, Stahl G, Sherman SK. 1999. Pharmacology and biological efficacy of a recombinant humanized single chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery utilizing cardiopulmonary bypass. Circulation (in press).
   
  
• Klein HG, Dodd RY, Dzik WH, Luban NL, Ness P, Pisciotto P, Schiff P, Snyder EL. Current status of solvent/detergent-treated frozen plasma. Transfusion 1998;38:102-107.
   
  
• Menitove JE, Snyder EL. Platelet transfusion practice: time for renewed consensus. Transfusion 1998;38:707-9.
   
  
• Snyder, EL. The status of transfusion medicine science and the role of the American Association of Blood Banks: the Journey Continues. Transfusion 1998;38:899-902.
   
  
• Snyder EL, et al. Effect of PEG-rHu megakaryocyte growth and development factor coupled with polyethylene glycol on the platelet storage lesion. Transfusion 1999;39:258-264.
   
  
• Perrotta, PL., Snyder EL. Effects of methylene blue-treated plasma on red cells and stored platelet concentrates. Transfusion 1999;39:63-9
   
  
• Burtness BA, Psyrri A, Rose M,. Snyder EL,.Cooper D. A phase I study of pacitaxel for mobilization of peripheral blood progenitor cells. Bone Marrow Transplantation 1999;23:311-15.
   
  
• McQuiston JH, Snyder EL, Chamberland ME Transmission of tickborne agents by blood transfusions: a review of potential risks. Transfusion (in press, 1999).
   
  
• Magriples U, Bernstein P, Snyder EL, Copel J. Can risk factor screening predict hepatitis C antibody reactivity- Am J Perinatology 1998;15:395-8.
   
  
• Debalak J, Shlomchik MJ, Snyder EL, . Krause DS. Isolation of T cell depleted CD34+ peripheral lood stem cells using the Isolex 300i magnetic cell separator. Bone Marrow Transplantation, (in press, 1999).
   
  
• Berger CL, .Snyder EL,.Edelson R. Rapid induction of human dendritic antigen presenting cells capable of initiating clinically relevant anti-tumor immunity. Nature Medicine, 1999 submitted.
   
  
• Burgess J. Snyder EL,. Moss TJ. Breast tumor contamination of peripheral blood stem cell harvests, II: tumor depletion by positive selection of CD34+ cells. Bone Marrow Transplantation, (in press, 1999).
   
  
• Snyder, EL., et al. Collection and postinfusion engraftment characteristics of mononuclear cells obtained using the Amicus separator. Transfusion, ( in press, 1999).
   
  
• Perrotta P, Snyder EL. Blood Component Therapy: Its Use and Complications In: Current Practice of Medicine. Bone R, Fitzgerald F. (series eds). Volume 2 (no 6). Duffy T, (section ed). 1999;1184-1194. Chapter 230.
   
  
• Snyder EL. The Official Requirements for Platelet Concentrates. Vox Sang, International Forum (in press, 1999).
   
  
• Snyder EL. Transfusion Reactions. In: Benz EJ, Cohen HJ, Furie B, Hoffman R, Shattil S (eds): Hematology Basic Principles and Practice 3rd ed. Churchill Livingstone, NY, 1999.
   
  
• Snyder EL, Judge J. Plasma. In: IM Roitt, PJ Delves (eds.) Encyclopedia of Immunology. Academic Press, London, 1998:1964-9.
   
  
• Snyder EL, Pisciotto P. Platelet Storage and Metabolism. In: Anderson K, Ness P (eds.) Scientific Basis of Transfusion Medicine, Implications for Clinical Practice. 2nd edition W.B. Saunders, Philadelphia, PA 1999.
   
  
• Rinder HR, Arbini A, Snyder EL, Platelet transfusions, optimal dosing and triggers for prophylactic use, in Stossel T (ed). Current Opinion in Hematology. Vol 6 (# 6), (in press, 1999).
   
  
• Stoddart L, Snyder, EL. Platelet Transfusion. J Intensive Care Medicine, (in press, 1999)
   
  
• Snyder EL. Role of Biological Response Modifiers in Platelet Transfusion. In: Segahatchian J, Snyder EL, Krailadsiri P (eds). Platelet Therapy: Current Status & Future Challenges. Elsevier Science, Netherlands, ( in press, 1999)
   
  
• Snyder EL. Platelet storage 1999-as good as it gets- Platelets (in press)
   
  
• Haley NR, Otter J, Snyder EL. AABB HPC Standards, and laboratory assessment/accreditation program. Cancer Research, Therapy and Control, (in press)
   
  
• Perrotta PL, Snyder EL. Blood Transfusion, In: Oxford Textbook of Medicine, Warrell, Cox, Firth, Benz, eds. 4th edition, Oxford University Press, (in press)
   
  
• Pisciotto P, Snyder EL, Platelets and Related products, in Silberstein L, Hillyer C (eds)., Blood Banking and Transfusion Medicine. Harcourt, Brace & Co.
   
  
• Stack. G. Mechanic S. Transfusion Therapy In: Clinical Laboratory Medicine, McClatchey KD, ed., Williams and Wilkins, Baltimore, 2000.
   
  
• Christensen J., Cotmore S.F. and Tattersall, P. Two New Members of the Emerging KDWK Family of Combinatorial Transcription modulators Bind as a Heterodimer to Flexibly-Spaced PuCGPy Half-Sites. Mol. Cell. Biol., 19, 7741-7750, 1999.
   
  
• Kestler, J., Neeb, B., Struyf, S., van Damme, J., Cotmore, S. F., D'Abramo, A. M. Jr., Tattersall, P., Rommelaere, J., Dinsart, C., and Cornelis, J. J. Cis-requirements for the efficient production of recombinant DNA vectors based on autonomous parvoviruses. Human Gene Therapy, 10, 1619-1632, 1999.
   
  
• Cotmore, S. F., D'Abramo, A. M. Jr., Ticknor, C. M. and Tattersall P. Controlled conformational transitions in the MVM virion expose the VP1 N-terminus and viral genome without particle disassembly.Virology, 254, 169-181, 1999.
   
  
• Agbandje-McKenna, M., Llamas-Saiz, A. L., Wang, F., Tattersall, P., and Rossmann, M. G. Functional implications of the structure of the murine parvovirus, minute virus of mice. Structure, 6, 1369-1381, 1998.
   
  
• Cotmore S.F. and Tattersall, P. High mobility group (HMG1/2) proteins are essential for initiating rolling-circle type DNA replication at a parvoviral hairpin origin. J.Virol., 72, 8477-84, 1998.
   
  
• Nüesch, J.P.F., Corbau, R., Tattersall, P. and Rommelaere, J. Biochemical activities of Minute Virus of Mice non-structural protein NS1 are modulated in vitro by the phosphorylation state of the polypeptide . J.Virol., 72, 8002-12, 1998.